These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6273180)

  • 21. Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion.
    Schürmeyer TH; Avgerinos PC; Gold PW; Gallucci WT; Tomai TP; Cutler GB; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1103-8. PubMed ID: 6092407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of single intravenously administered doses of dexamethasone on response to the adrenocorticotropic hormone stimulation test in dogs.
    Kemppainen RJ; Sartin JL; Peterson ME
    Am J Vet Res; 1989 Nov; 50(11):1914-7. PubMed ID: 2559631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease.
    Arvat E; Ramunni J; Maccagno B; Giordano R; Broglio F; Deghenghi R; Boscaro M; Ghigo E
    Neuroendocrinology; 1999 Sep; 70(3):200-6. PubMed ID: 10516483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High intensity exercise promotes escape of adrenocorticotropin and cortisol from suppression by dexamethasone: sexually dimorphic responses.
    Deuster PA; Petrides JS; Singh A; Lucci EB; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3332-8. PubMed ID: 9745450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N; Diederich S; Oelkers W
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioavailability of dexamethasone. II. Dexamethasone phosphate.
    Hare LE; Yeh KC; Ditzler CA; McMahon FG; Duggan DE
    Clin Pharmacol Ther; 1975 Sep; 18(3):330-7. PubMed ID: 1100302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [ACTH in the dexamethasone suppression test].
    Jungmann E; Schulz F; Magnet W; Schöffling K
    Med Klin Prax; 1982 Jan; 77(1):33-5. PubMed ID: 6280027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects.
    von Bardeleben U; Holsboer F; Stalla GK; Müller OA
    Life Sci; 1985 Oct; 37(17):1613-8. PubMed ID: 2997567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test.
    Nickelsen T; Lissner W; Schöffling K
    Exp Clin Endocrinol; 1989; 94(3):275-80. PubMed ID: 2560985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous and glucocorticoid-inhibited adrenocorticotropic hormone and cortisol secretion are similar in healthy young and old men.
    Waltman C; Blackman MR; Chrousos GP; Riemann C; Harman SM
    J Clin Endocrinol Metab; 1991 Sep; 73(3):495-502. PubMed ID: 1651956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulsatile human corticotropin-releasing hormone prevents dexamethasone-induced suppression of the plasma cortisol response to hypoglycemia in normal men.
    Avgerinos PC; Kiamouris CK; Petrakos IP; Kleanthous IK; Zorzos PA; Dimitriadis TN; Raptis SA; Cutler GB
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1358-61. PubMed ID: 1331166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of dermal dexamethasone application on ACTH and both basal and ACTH-stimulated cortisol concentration in normal horses.
    Abraham G; Allersmeier M; Gottschalk J; Schusser GF; Hoppen HO; Ungemach FR
    J Vet Pharmacol Ther; 2009 Aug; 32(4):379-87. PubMed ID: 19614843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-lipotropin/adrenocorticotropic hormone responses to corticotropin releasing hormone, hypoglycemia, metyrapone and dexamethasone in normal human subjects.
    Castro M; Moreira AC
    Braz J Med Biol Res; 1990; 23(11):1107-15. PubMed ID: 1966779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man.
    Ur E; Capstick C; McLoughlin L; Checkley S; Besser GM; Grossman A
    Neuroendocrinology; 1995 Feb; 61(2):191-7. PubMed ID: 7753338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone and prednisolone in the horse: pharmacokinetics and action on the adrenal gland.
    Toutain PL; Brandon RA; de Pomyers H; Alvinerie M; Baggot JD
    Am J Vet Res; 1984 Sep; 45(9):1750-6. PubMed ID: 6497132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: a comparison.
    Avgerinos PC; Yanovski JA; Oldfield EH; Nieman LK; Cutler GB
    Ann Intern Med; 1994 Sep; 121(5):318-27. PubMed ID: 8042820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Normal suppression" to dexamethasone in Cushing's disease: an expression of decreased metabolic clearance for dexamethasone.
    Caro JF; Meikle AW; Check JH; Cohen SN
    J Clin Endocrinol Metab; 1978 Sep; 47(3):667-70. PubMed ID: 233679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.